Total Payments
$6,440
2024 Payments
$1,081
Companies
47
Transactions
395
Medicare Patients
6,008
Medicare Billing
$545,100
Payment Breakdown by Category
Food & Beverage$6,423 (99.7%)
Education$17.01 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,423 | 393 | 99.7% |
| Education | $17.01 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $968.52 | 53 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $931.85 | 60 | $0 (2024) |
| GlaxoSmithKline, LLC. | $519.83 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $408.46 | 31 | $0 (2022) |
| Novo Nordisk Inc | $396.59 | 27 | $0 (2024) |
| Lilly USA, LLC | $279.32 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $254.09 | 15 | $0 (2023) |
| Allergan, Inc. | $253.12 | 21 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $240.93 | 16 | $0 (2024) |
| Esperion Therapeutics, Inc. | $219.51 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,081 | 51 | ABBVIE INC. ($300.47) |
| 2023 | $981.81 | 52 | AbbVie Inc. ($291.80) |
| 2022 | $1,124 | 59 | ABBVIE INC. ($237.34) |
| 2021 | $806.69 | 52 | AbbVie Inc. ($138.91) |
| 2020 | $742.96 | 54 | GlaxoSmithKline, LLC. ($165.34) |
| 2019 | $446.27 | 32 | Novo Nordisk Inc ($103.86) |
| 2018 | $649.84 | 50 | SANOFI-AVENTIS U.S. LLC ($117.05) |
| 2017 | $607.11 | 45 | AstraZeneca Pharmaceuticals LP ($130.92) |
All Payment Transactions
395 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.97 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: NEUROLOGY | ||||||
| 09/26/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $15.33 | General |
| Category: Narcoplepsy | ||||||
| 09/09/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/05/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Neuromodulation | ||||||
| 09/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: PAIN | ||||||
| 08/29/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), AIRSUPRA | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,696 | 2,960 | $514,974 | $143,434 |
| 2022 | 22 | 1,573 | 2,758 | $462,214 | $148,198 |
| 2021 | 21 | 1,350 | 2,293 | $429,734 | $134,781 |
| 2020 | 21 | 1,389 | 2,319 | $350,059 | $118,687 |
Total Patients
6,008
Total Services
10,330
Medicare Billing
$545,100
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 192 | 547 | $103,930 | $44,932 | 43.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 478 | 640 | $92,800 | $39,002 | 42.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 187 | 187 | $79,475 | $16,700 | 21.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 151 | 154 | $70,070 | $14,317 | 20.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 157 | 157 | $26,690 | $12,526 | 46.9% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 167 | 275 | $104,250 | $8,440 | 8.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,230 | $1,856 | 43.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 41 | 42 | $3,990 | $1,715 | 43.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 70 | 156 | $10,140 | $1,481 | 14.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 17 | 23 | $1,265 | $932.65 | 73.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 15 | 31 | $2,480 | $502.82 | 20.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 48 | $3,120 | $456.96 | 14.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 22 | $2,200 | $202.09 | 9.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 26 | 56 | $1,680 | $179.76 | 10.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 30 | 39 | $1,950 | $83.81 | 4.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 32 | 136 | $4,760 | $49.97 | 1.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 53 | 372 | $1,488 | $32.31 | 2.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 16 | 57 | $456.00 | $23.71 | 5.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 588 | $111,765 | $52,242 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 444 | 581 | $84,270 | $38,202 | 45.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 125 | 126 | $57,330 | $12,022 | 21.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 124 | 124 | $52,700 | $11,389 | 21.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 105 | 105 | $17,850 | $8,895 | 49.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $15,275 | $8,301 | 54.3% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 98 | 138 | $72,900 | $4,348 | 6.0% |
About Dr. David Ware, M.D
Dr. David Ware, M.D is a Family Medicine healthcare provider based in Eunice, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801852207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Ware, M.D has received a total of $6,440 in payments from pharmaceutical and medical device companies, with $1,081 received in 2024. These payments were reported across 395 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($6,423).
As a Medicare-enrolled provider, Ware has provided services to 6,008 Medicare beneficiaries, totaling 10,330 services with total Medicare billing of $545,100. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Eunice, LA
- Active Since 04/25/2006
- Last Updated 08/26/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801852207
Products in Payments
- FARXIGA (Drug) $718.97
- VRAYLAR (Drug) $570.75
- TRELEGY ELLIPTA (Drug) $364.19
- QULIPTA (Drug) $287.65
- UBRELVY (Drug) $249.75
- JARDIANCE (Drug) $237.92
- NEXLETOL (Drug) $219.51
- TRINTELLIX (Drug) $218.16
- EDUCATION (Device) $188.69
- Sunosi (Drug) $184.90
- Ozempic (Drug) $172.59
- SOLIQUA (Drug) $167.49
- LUNA (Device) $165.63
- SOLIQUA 100/33 (Biological) $144.22
- NURTEC ODT (Drug) $115.22
- Saxenda (Drug) $94.86
- Veozah (Drug) $93.83
- TRULICITY (Drug) $79.45
- EMGALITY (Drug) $76.46
- VYVANSE (Drug) $74.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Eunice
Dr. Ty Hargroder, Md, MD
Family Medicine — Payments: $6,894
Family Medicine $6,894
Reginald Segar, Md, MD
Family Medicine — Payments: $5,207
Family Medicine $5,207
Dr. Brian Heinen, M.d, M.D
Family Medicine — Payments: $4,800
Family Medicine $4,800
Dr. Jade Heinen, M.d, M.D
Family Medicine — Payments: $4,049
Family Medicine $4,049
John Rainey, M.d, M.D
Family Medicine — Payments: $3,969
Family Medicine $3,969
Zebediah Stearns, M.d, M.D
Family Medicine — Payments: $2,827
Family Medicine $2,827